Evidence map›Paper›PMID 42031149›Full record

ArticlePharmacological research2026

Nuclear receptors in metabolism and diseases: Mechanistic and therapeutic insights.

Hongbing Wang, Taosheng Chen, Huichang Bi

Abstract readEditorial
In one paragraph

Article in Pharmacological research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hongbing WangDepartment of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA. Electronic address: hongbing.wang@rx.umaryland.edu.
Taosheng ChenDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, 38105-3678, USA. Electronic address: taosheng.chen@stjude.org.
Huichang BiSchool of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, PR China. Electronic address: bihchang@smu.edu.cn.

Funding

Impact of CAR and Nrf2 dual activation on cyclophosphamide bioactivation and doxorubicin detoxificationR01CA295603 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI WANG, HONGBING, XUE, FENGTIAN · 2025 to 2025
$2.8M
NCI NIH HHS R01 CA295603
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42031149
PMCPMC13492392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.